Veroscience Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VEROSCIENCE, and when can generic versions of VEROSCIENCE drugs launch?
VEROSCIENCE has one approved drug.
There are thirteen US patents protecting VEROSCIENCE drugs.
There are thirty-three patent family members on VEROSCIENCE drugs in thirteen countries.
Drugs and US Patents for Veroscience
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 9,993,474 | ⤷ Sign Up | ⤷ Sign Up | ||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 10,688,155 | ⤷ Sign Up | ⤷ Sign Up | ||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 8,613,947 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 9,352,025 | ⤷ Sign Up | ⤷ Sign Up | ||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 10,688,094 | ⤷ Sign Up | ⤷ Sign Up | ||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 9,192,576 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Veroscience
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 8,137,992 | ⤷ Sign Up |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,468,755 | ⤷ Sign Up |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 8,137,993 | ⤷ Sign Up |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 8,137,994 | ⤷ Sign Up |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 7,888,310 | ⤷ Sign Up |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,756,513 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Veroscience Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2844229 | ⤷ Sign Up |
European Patent Office | 4342536 | ⤷ Sign Up |
Brazil | PI1009619 | ⤷ Sign Up |
Spain | 2755081 | ⤷ Sign Up |
Japan | 2016026168 | ⤷ Sign Up |
Australia | 2016202572 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.